Rosett Max

Track

Insider profile

Performance

Overall performance
3.3
Performance over holding periods
3.3
30 days 90 days 120 days
Average return 26% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Rosett Max's trades of Immunome Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-17 2026-06-15
US Immunome Inc (IMNM)
PlS Planned sale
45,405 -18.0%
286.48
US$2,869,621 		45,405 -18.0% 286.48 US$2,869,621
2026-06-15 2026-06-15
US Immunome Inc (IMNM)
PrS Proposed sale
14,982
252.99
US$3,473,062 		14,982 252.99 US$3,473,062
2026-04-03 2026-04-02
US Immunome Inc (IMNM)
PlS Planned sale
26,235 -47.3%
124.65
US$543,643 		26,235 -47.3% 124.65 US$543,643
2026-04-03 2026-04-02
US Immunome Inc (IMNM)
PlS Planned sale
63,656 -53.5%
21.91
US$1,394,703 		63,656 -53.5% 21.91 US$1,394,703
2026-04-03 2026-04-02
US Immunome Inc (IMNM)
PrS Proposed sale
65,000
21.92
US$1,425,085 		65,000 21.92 US$1,425,085
2026-04-02 2026-04-02
US Immunome Inc (IMNM)
PrS Proposed sale
65,000
72.67
US$4,723,550 		65,000 72.67 US$4,723,550
2024-09-20 2024-09-19
US Immunome Inc (IMNM)
S Sale
14,380 -23.2%
16.01
US$230,224 		14,380 -23.2% 16.01 US$230,224
2024-09-19 2024-09-19
US Immunome Inc (IMNM)
PrS Proposed sale
14,380
16.01
US$230,211 		14,380 16.01 US$230,211